PixelSky Capital Launches ₹400 Crore Secondaries Fund
In collaboration with entrepreneur Hitesh Ahuja, Bengaluru-based investment bank IndigoEdge has launched PixelSky Capital. This is a newly launched secondary fund with a target corpus of ₹400 crore. The funds will be utilised in late-stage technology and consumer companies that are ready for IPO in the next 36 to 48 months.
The new venture aims to back eight companies with an average investment size of around ₹40 to ₹50 crore. PixelSky has already locked the online cosmetics retailer Purplle.com.
IndigoEdge is known for facilitating 150+ transactions that are worth $3 billion. And with this new venture, the company is expanding into fund management as well, targeting the emerging Indian late-stage startup market.
“We are grateful to all our early believers as we set out to build our first fund in red hot Indian secondaries space – we believe private markets ecosystem in its two decades plus has reached a point where distribution (DPI) is the new IRR and time for novel exit options have come for $400+ billion invested ecosystem.” expressed Hitesh Ahuja on LinkedIn.
- Gangadhar Krishnamoorthy appointed as Senior Vice President – Manufacturing & SCM Excellence at JSW SteelJSW Steel announced the appointment of Gangadhar Krishnamoorthy as Senior… Read more: Gangadhar Krishnamoorthy appointed as Senior Vice President – Manufacturing & SCM Excellence at JSW Steel
- Sunanda Khaitan appointed as Chief Marketing Officer – Beauty & Wellbeing at UnileverHindustan Unilever Limited (HUL) has appointed Sunanda Khaitan as the… Read more: Sunanda Khaitan appointed as Chief Marketing Officer – Beauty & Wellbeing at Unilever
- Rachit Mishra appointed as Head Brand & Digital Communications at ArcelorMittal Nippon Steel IndiaArcelorMittal Nippon Steel India (AM/NS India) has named Rachit Mishra… Read more: Rachit Mishra appointed as Head Brand & Digital Communications at ArcelorMittal Nippon Steel India
- Zuellig Pharma Announces Acquisition of Zam-Buk® and Vapex® from BayerZuellig Pharma has announced the acquisition of all rights, title,… Read more: Zuellig Pharma Announces Acquisition of Zam-Buk® and Vapex® from Bayer
